PMC6452791_01
Anti-NMDA receptor antibodies in patient's cerebrospinal fluid and serum. Anti-NMDA receptor antibodies were positive in cerebrospinal fluid (IgG, 1:32) (A) and serum (IgG, 1:320) (B) before immunotherapy. The level of anti-NMDA receptor antibodies significantly decreased in cerebrospinal fluid (IgG, 1:3.2) (C) and serum (IgG, 1:32) (D) after 5 months of immunotherapy.. Abbreviation: NMDA, N-methyl-D-aspartate.
ndt-15-773Fig1.jpg
PMC6452791_01_ndt-15-773Fig1.jpg
f1-ndt-15-773
Immunological analyses were positive for specific anti-NMDA receptor antibodies in both CSF (IgG, 1:32) and serum (IgG, 1:320) (Figure 1A and B). His symptoms continued to improve after discharge, and the level of antibodies significantly decreased in cerebrospinal fluid (IgG, 1:3.2) and serum (IgG, 1:32) (Figure 1C and D) after 5 months of immunotherapy.